Personalized Regenerative Aesthetic Care & Dedicated International Patient Concierge
Anti-Obesity Injectables · Needs Clinic Confirmation
Mounjaro
Mounjaro (tirzepatide) is a prescription medication for diabetes and obesity treatment that works by simultaneously activating two incretin hormone receptors.
Schedule a ConsultationMounjaro

What Is Mounjaro? Understanding GIP/GLP-1 Dual Agonist Weight Management
Mounjaro (tirzepatide) is a prescription medication for diabetes and obesity treatment that works by simultaneously activating two incretin hormone receptors — GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). This dual-receptor mechanism distinguishes Mounjaro from earlier generation weight management medications that acted on only a single receptor pathway.
By stimulating both GIP and GLP-1 receptors simultaneously, Mounjaro produces three concurrent effects: increased satiety through direct signaling to the brain's appetite center, improved insulin resistance, and promoted fat metabolism. The combined result is a physiologically grounded approach to weight management — reducing food intake naturally, stabilizing blood sugar, and improving the body's metabolic efficiency at the same time. Many patients notice visible change within 12 weeks of beginning treatment.
At Vellicell, Mounjaro is prescribed only following a thorough physician consultation that assesses health status, underlying conditions, and current medications. Dosing begins conservatively at 2.5mg and is adjusted stepwise according to individual response. Treatment is monitored through regular follow-up visits — Mounjaro is a prescription medication requiring ongoing physician oversight, not a standalone injectable administered without medical supervision.
Who Is a Candidate for Mounjaro Prescription Treatment?
Mounjaro is a prescription medication suited to patients whose weight management has not been achievable through diet and exercise alone, or who have metabolic conditions requiring concurrent management. Ideal candidates include:
Those who have found weight loss difficult through diet and exercise alone and have reached a physiological plateau that lifestyle modification is no longer overcoming
Patients with elevated blood sugar or a pre-diabetes diagnosis who want to address both weight and metabolic risk simultaneously
Those wanting to manage weight and blood sugar together within a single supervised programme rather than separately
Individuals who have repeatedly struggled with appetite control — finding that hunger consistently undermines dietary effort — and want a physiological intervention that addresses appetite regulation directly
Patients who want safe, systematic weight management under physician supervision with structured dosing, regular monitoring, and honest communication about progress and expectations
Those without contraindications — Mounjaro is not appropriate for patients with a history of pancreatitis or certain thyroid conditions; this is assessed thoroughly at consultation
Meet the Physician at Vellicell Clinic
|
Dr. Geon Kim, MD |
Dr. Kim Geon — Chief Director MD, Korea University College of Medicine | Resident, Korea University Medical Center | Former Chief Director, Maypure Clinic (Suji) | Member, Korean Society for Laser Dermatology and Hair · Korean Filler Society · Korean Lifting Society
Mounjaro at Vellicell is prescribed exclusively by physician directors following individual health assessment. Dr. Kim conducts the full consultation — evaluating health status, underlying conditions, and medication history — before any prescription is issued. Starting dose, titration schedule, and monitoring frequency are determined individually based on each patient's health profile. No prescription is issued without this assessment, and no dosing decision is made without physician review of the patient's ongoing response.
How Mounjaro Works: Dual Incretin Mechanism
GIP Receptor Activation: GIP (glucose-dependent insulinotropic polypeptide) is an incretin hormone that plays a role in insulin secretion, fat storage regulation, and satiety signaling. Mounjaro's activation of the GIP receptor contributes to improved fat metabolism and enhanced insulin efficiency — addressing aspects of metabolic function that GLP-1 alone does not target.
GLP-1 Receptor Activation: GLP-1 (glucagon-like peptide-1) is an incretin hormone that signals the brain's appetite center to reduce hunger, slows gastric emptying to prolong satiety, and supports blood sugar regulation by enhancing insulin secretion in response to food intake. GLP-1 receptor agonists have been the foundation of medical weight management for several years; Mounjaro adds GIP activation on top of this established mechanism.
Combined Effect: By activating both pathways simultaneously, Mounjaro produces a more comprehensive metabolic response than single-receptor medications — with appetite suppression, blood sugar stabilization, insulin resistance improvement, and fat metabolism promotion occurring together. This dual action is the basis for the meaningful weight loss outcomes observed in patients for whom diet and exercise alone have been insufficient.
Mounjaro Prescription Process at Vellicell Clinic

Physician Consultation and Health Assessment — Your physician conducts a detailed assessment of your health status, underlying conditions, thyroid history, pancreatitis history, and current medications; candidacy is confirmed and contraindications are ruled out before any prescription is issued
Starting Dose Prescription — Treatment begins at 2.5mg, the conservative starting dose; your physician explains the titration schedule, what to expect during the initial weeks, and how to recognize and report any adverse reactions
Stepwise Dose Adjustment — Dose is adjusted gradually according to your individual response and tolerance; increases are made only when clinically appropriate based on monitoring data
Regular Follow-Up Monitoring — Scheduled return visits allow the physician to assess weight changes, blood sugar response, tolerability, and any adverse reactions; programme adjustments are made based on objective monitoring rather than assumption
Ongoing Medication Guidance — Strict adherence to medication guidance is essential; misuse or self-adjustment of dosing outside physician supervision can cause serious adverse effects
Expected Results, Safety, and Important Considerations
Mounjaro's clinical evidence supports meaningful weight reduction for patients who meet appropriate candidacy criteria and follow the physician-directed dosing programme. Many patients notice visible change within 12 weeks of beginning treatment, with continued progress as dosing is optimized over subsequent months. Blood sugar stabilization and improved insulin efficiency develop alongside weight reduction for patients with elevated glucose or pre-diabetes.
Mounjaro is a prescription medication with a defined safety profile that must be respected. It is not appropriate for patients with a history of pancreatitis or certain thyroid conditions — these are assessed and discussed at consultation. Common early side effects include nausea, reduced appetite, and mild gastrointestinal symptoms as the body adjusts to the medication; these typically reduce as the body acclimates. Misuse or dose escalation outside physician guidance can cause serious adverse effects including sleep disruption, anxiety, and depression. Abdominal pain, vomiting, or severe dizziness that persists should prompt an immediate clinic visit.
Mounjaro is a medical treatment — not a cosmetic injectable — and requires ongoing physician oversight throughout the prescription period. Results vary by individual, and the programme is designed around each patient's specific health profile, not a standard outcome target.
Why Choose Vellicell Clinic for Mounjaro Prescription?

Mounjaro at Vellicell is prescribed only by physician directors who have conducted a full individual health assessment — confirming candidacy, ruling out contraindications, and designing a dosing and monitoring programme appropriate for each patient's specific health profile. The clinic's private, physician-led model means that every Mounjaro consultation is conducted in a 1:1 setting with one of the clinic's two director physicians, with full medical transparency and no delegation to non-physician staff.
For international patients, Vellicell's multilingual consultation capability — in English, Chinese, Japanese, and Thai — ensures that health history, medication guidance, and monitoring expectations are fully understood across language barriers. The clinic is open every day of the year, including Sundays and public holidays, supporting the scheduling needs of patients managing ongoing prescription programmes.
Physician-only prescription — Mounjaro issued exclusively following full health assessment by MD-qualified specialist directors
Conservative, monitored dosing — starts at 2.5mg with stepwise adjustment based on individual response monitoring
Contraindication screening — pancreatitis history, thyroid conditions, and medication interactions assessed before prescription
Ongoing monitoring programme — regular follow-up visits to assess weight change, tolerability, and dose appropriateness throughout treatment
Patient Perspectives
Weight and Blood Sugar Management Patient, 40s
After years of attempting weight loss through diet and exercise with limited sustained success, this patient consulted Dr. Kim following a pre-diabetes diagnosis. A full health assessment confirmed Mounjaro candidacy, and a conservative starting programme was designed. With regular monitoring visits and stepwise dose adjustment, he experienced progressive weight reduction and improved blood sugar readings over the following months — addressing both concerns within a single supervised programme.
Appetite Control Patient, 30s
Repeated diet attempts had been consistently undermined by appetite that returned strongly despite initial effort. Following physician assessment confirming no contraindications, this patient began a Mounjaro programme at Vellicell. The physiological appetite regulation effect reduced the hunger-driven pattern that had previously disrupted dietary adherence, supporting more consistent progress toward her weight management goals.
Begin Your Mounjaro Programme at Vellicell Clinic
Weight resistance driven by appetite dysregulation and metabolic inefficiency is a physiological condition — and it responds to physiological solutions. Mounjaro's dual GIP/GLP-1 mechanism addresses the hormonal root of appetite and blood sugar simultaneously, under physician supervision that ensures safe, individually calibrated dosing and honest progress monitoring. If diet and exercise alone have not been sufficient, Vellicell is ready to assess whether Mounjaro is an appropriate next step for your health profile.
\[Book Your Mounjaro Consultation Today — Speak Directly with a Physician Director\]
Multilingual support available in English, Chinese, Japanese, and Thai. Open daily, including Sundays and public holidays.
Other Services
Explore additional treatments offered by our specialists.
Wegovy
Wegovy (semaglutide) is a prescription injectable medication for obesity treatment classified as a GLP-1 (glucagon-like peptide-1) receptor agonist.
Learn More
Volnewmer Lifting
Volnewmer is a non-surgical radiofrequency lifting treatment that delivers 6.78MHz monopolar RF thermal energy directly to the dermis, inducing tissue coagulation and triggering a collagen regeneration response.
Learn More
Ultherapy Prime
Ultherapy Prime is an advanced non-surgical lifting treatment that uses focused ultrasound energy to target the SMAS layer.
Learn More
